Correspondence 0001193125-24-113865 from Q32 Bio Inc. (QTTB)
Q32 Bio Inc.
Date: April 25, 2024 · CIK: 0001661998 · Accession: 0001193125-24-113865
AI Filing Summary & Sentiment
Reasoning
File numbers found in text: 333-278829
Letter
Q32 Bio Inc.
830 Winter Street
Waltham, MA
April 25, 2024
VIA EDGAR
Securities and Exchange Commission
Division of Corporation Finance – Office of Life Sciences
100 F Street, N.E.
Washington, D.C. 20549
Re: Q32 Bio Inc.
Registration Statement on Form S-1
File No. 333-278829
Request for Acceleration
Ladies and Gentlemen:
Pursuant to Rule 461 under the Securities Act of 1933, as amended (the “Act”), Q32 Bio Inc. (the “Company”) hereby requests acceleration of the effective date of its Registration Statement on Form S-1 (File No. 333-278829) (the “Registration Statement”), so that it may become effective at 4:00 pm Eastern time on April 29, 2024, or as soon thereafter as practicable, unless we or our outside counsel, Goodwin Procter LLP, request by telephone that such Registration Statement be declared effective at some other time. In making this acceleration request, the Company acknowledges that it is aware of its responsibilities under the Act.
If you have any questions regarding this request, please contact Sarah Ashfaq of Goodwin Procter LLP at (212) 459-7238.
Very truly yours,
Q32 BIO
INC.
Show Raw Text
CORRESP 1 filename1.htm CORRESP Q32 Bio Inc. 830 Winter Street Waltham, MA 02451 April 25, 2024 VIA EDGAR Securities and Exchange Commission Division of Corporation Finance – Office of Life Sciences 100 F Street, N.E. Washington, D.C. 20549 Re: Q32 Bio Inc. Registration Statement on Form S-1 File No. 333-278829 Request for Acceleration Ladies and Gentlemen: Pursuant to Rule 461 under the Securities Act of 1933, as amended (the “Act”), Q32 Bio Inc. (the “Company”) hereby requests acceleration of the effective date of its Registration Statement on Form S-1 (File No. 333-278829) (the “Registration Statement”), so that it may become effective at 4:00 pm Eastern time on April 29, 2024, or as soon thereafter as practicable, unless we or our outside counsel, Goodwin Procter LLP, request by telephone that such Registration Statement be declared effective at some other time. In making this acceleration request, the Company acknowledges that it is aware of its responsibilities under the Act. If you have any questions regarding this request, please contact Sarah Ashfaq of Goodwin Procter LLP at (212) 459-7238. Very truly yours, Q32 BIO INC. By: /s/ Jodie Morrison Name: Jodie Morrison Title: Chief Executive Officer cc: Sarah Ashfaq, Goodwin Procter LLP